Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
2,838,079
-
Shares change
-
+35,365
-
Total reported value, excl. options
-
$953,694
-
Value change
-
+$5,588
-
Put/Call ratio
-
5.57%
-
Number of buys
-
12
-
Number of sells
-
-8
-
Price
-
$0.336
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q4 2024
33 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q4 2024.
IGC Pharma, Inc. - COM NEW (IGC) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,838,079 shares
.
Largest 10 shareholders include BlackRock, Inc. (703,798 shares), GEODE CAPITAL MANAGEMENT, LLC (669,685 shares), VANGUARD GROUP INC (645,166 shares), STATE STREET CORP (165,307 shares), Squarepoint Ops LLC (125,966 shares), NORTHERN TRUST CORP (113,407 shares), DEARBORN PARTNERS LLC (109,401 shares), GOLDMAN SACHS GROUP INC (65,541 shares), TWO SIGMA SECURITIES, LLC (60,863 shares), and TRUIST FINANCIAL CORP (36,667 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.